Research across Diabetes
Related studies from across the Diabetes family.
Questions about Type 1 Diabetes
Does the FDA approved drug Tzield delay the onset of Stage 3 Type 1 diabetes?
Yes, the FDA-approved drug Tzield (teplizumab) delays the onset of Stage 3 type 1 diabetes in people with Stage 2 disease.
Full answer →Can semaglutide help reduce the total daily insulin dose for adults with Type 1 diabetes?
Yes, semaglutide can reduce total daily insulin dose in adults with type 1 diabetes and overweight or obesity, based on clinical trial and real-world data.
Full answer →All Type 1 Diabetes Articles
- Pancreatic tissue engineering faces vascularization hurdle in type 1 diabetes therapy
- CAR technology for autoimmune disorders, infectious diseases, fibrotic lesions, inflammatory bowel disease, and type 1 diabetes is reviewed
- Meta-analysis finds no link between early-life antibiotics and type 1 diabetes risk
- scFv-based biologics show potential for immunomodulation in type 1 and type 2 diabetes
- Early-life antibiotic exposure linked to modest increased risk of childhood type 1 diabetes
- Women with Type 1 Diabetes have a 2.10 times higher risk of female sexual dysfunction compared to age-matched controls
- Systematic review and meta-analysis on probiotics for glycemic control in pediatric type 1 diabetes
- Case report of high-dose ceftazidime in an 84-year-old man with skull base osteomyelitis and type 1 diabetes
- Systematic review finds no difference in hypoglycemia or ketoacidosis between insulin types
- Narrative review discusses CAR-T and HSC therapies for cancer and autoimmune conditions
- Narrative review of transposable element methylation in autoimmune diseases
- Semaglutide reduces insulin dose in adults with type 1 diabetes and obesity
- Umbrella review identifies risk factors and protective factors for male infertility and semen quality
- Meta-analysis finds slight IQ difference in children with type 1 diabetes versus peers
- Barriers and promoters to CGM and AID use in youth with T1D and public insurance
- FDA Approves Tzield (teplizumab) to Delay Onset of Stage 3 Type 1 Diabetes
- Beta-cell stress responses contribute to early Type 1 diabetes development and disease progression
- Meta-analysis of sex differences in insulin therapy outcomes for adults with Type 1 and Type 2 diabetes
- Systematic review and meta-analysis of integrative therapies for Type 1 Diabetes Mellitus
- Autoimmune Thyroiditis Prevalence Higher in Obese Women With PCOS in Retrospective Cohort Analysis
- Meta-analysis of adjunctive SGLT2 inhibitors in type 1 diabetes shows mixed safety and efficacy signals
- Machine learning model predicts in-hospital hypoglycemia in Chinese adults with type 1 diabetes
- Observational MRI study links impaired hypoglycemia awareness to blunted cerebral blood flow responses in type 1 diabetes
- Cadonilimab therapy in cervical cancer associated with new-onset type 1 diabetes and diabetic ketoacidosis in a case report
- Narrative review examines immune modulation strategies for beta-cell replacement in type 1 diabetes
- Meta-analysis finds high prevalence of adverse outcomes in African women with hyperglycaemia in pregnancy
- Overweight status at diagnosis in Kuwaiti children with new-onset type 1 diabetes is associated with milder clinical presentation and lower HbA1c
- App-supported resistance training linked to lean mass and bone gains in youth with type 1 diabetes
- Individualized insulin strategies may improve glycemic control in pediatric T1DM with exogenous insulin antibody syndrome
- Insulin dose reduction during exercise yields similar glucose effects with ultra-rapid and rapid aspart
- Higher HbA1c linked to reduced cortical thickness, gray matter in youth; effect stronger in deprived neighborhoods
- GLP-1 Receptor Agonist Use in Wolfram Syndrome Shows No Glycemic or BMI Benefit, Common GI Effects
- Lipoprotein(a) shows substantial longitudinal variability in children with type 1 diabetes
- Youth diabetes incidence increased from 2002-2015, with higher rates of increase in minority populations
- Pilot RCT Shows Feasibility of Digital Hypoglycemia Intervention in Type 1 Diabetes
- Tubeless automated insulin delivery reduces HbA1c more than multiple daily injections in type 1 diabetes
- Genetic study links H. pylori susceptibility to HLA and innate immunity genes, suggests causal disease relationships
- Meta-analysis finds 8.33% pooled prevalence of new-onset diabetes after SARS-CoV-2 infection in adults
- Chinese APS-1 patients show recurrent AIRE gene deletion, male predominance, and low classic triad incidence
- GADA test shows high specificity but moderate sensitivity for adult-onset type 1 diabetes